Cognitive remission: a novel objective for the treatment of major depression?

Medicin og biovidenskab

• Major Depressive Disorder 100%
• Depression 63%
• Cognitive Dysfunction 43%
• Antidepressive Agents 23%
• Therapeutics 15%
• Lisdexamfetamine Dimesylate 14%
• Vortioxetine 14%
• Acetylcarnitine 12%
• Galantamine 12%
• Modafinil 12%
• Nootropic Agents 12%
• Randomized Controlled Trials 11%
• Thioctic Acid 11%
• coenzyme Q10 11%
• Minocycline 10%
• Scopolamine 10%
• Curcumin 9%
• Acetylcysteine 9%
• Omega-3 Fatty Acids 9%
• Melatonin 9%
• Erythropoietin 9%
• Methionine 9%
• Executive Function 9%
• Angiotensin-Converting Enzyme Inhibitors 8%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 8%
• Workforce 8%
• Hypoglycemic Agents 8%
• Memory 6%
• Insulin 5%